BioMerieux (STU:EYWN) Short Percentage of Float


STU:EYWN BioMerieux SA STU:EYWN
84 GF Score
Price €70.75
GF Value €109.28
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is BioMerieux Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

STU:EYWN vs TMO, DHR, IDXX: Short Percentage of Float Comparison

For the Diagnostics & Research subindustry, BioMerieux's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioMerieux Short Percentage of Float vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, BioMerieux's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where BioMerieux's Short Percentage of Float falls into.


STU:EYWN
84GF Score
BioMerieux SA STU:EYWN
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is BioMerieux (STU:EYWN) Overvalued in 2026?

Based on GuruFocus' analysis, BioMerieux stock appears to be undervalued. The current stock price of €70.75 is trading 35.3% below its estimated GF Value™ of €109.28. GuruFocus considers BioMerieux to be Significantly Undervalued.

Key valuation signals for STU:EYWN:

  • Short Percentage of Float:
  • GF Value™: €109.28 vs. price of €70.75 (35.3% below fair value)
  • GF Score™: 84/100 with 3 warning signs

No single metric tells the full story. See the STU:EYWN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BioMerieux Business Description

Address Marcy l’Etoile, Lyon, FRA, 69280
BioMérieux designs, develops, and manufactures a broad portfolio of in vitro diagnostics for detecting disease-causing pathogens and contamination. The company operates in four segments: molecular biology (42% of 2024 sales), microbiology (33%), immunoassays (10%), and industrial applications (about 15%). The Americas account for the largest portion of the firm's revenue (40%), followed by Asia-Pacific (27%) and Europe, the Middle East, and Africa (27%). BioMérieux is headquartered in Marcy-l'Étoile, France.
84GF Score

Get the complete analysis for STU:EYWN

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€70.75
Price
€109.28
GF Value